Search Results (107)

Brazil is characterized by high levels of solar exposure, which may compromise skin health due to ultraviolet radiation (UVR), particularly among individuals with darker skin tones who often underuse photoprotective measures. Although darker skin has been hypothesized to exhibit greater resistance to UVR, robust evidence remains limited. This study aimed to investigate the susceptibility of the stratum corneum (SC) of Black individuals to UV-induced lipid peroxidation using the HPLC–TBARS–EVSC protocol. SC samples were collected from the forearms of nine participants by tape stripping and subsequently exposed to an artificial UV radiation source. Lipid peroxidation was quantified through the detection of the malondialdehyde-thiobarbituric acid (MDA-TBA₂) adduct using high-performance liquid chromatography. Following UV exposure, a statistically significant increase in lipid peroxidation was observed, corresponding to an approximate 297% elevation in MDA-TBA₂ levels (p < 0.05). These findings demonstrate that the SC of Black skin is susceptible to UV-induced oxidative damage under the tested conditions. The results support the use of phototype-independent biochemical markers to assess photodamage and reinforce the need for effective photoprotection strategies in individuals with darker skin tones. Full article

Background: Solar lentigines are common epidermal hyperpigmented macules associated with chronic ultraviolet exposure and photoaging. Objective: To describe a standardized 532 nm green laser protocol for solar lentigines and to place these observations within a narrative review with a structured PubMed/Medline literature search. Methods: Five patients (two women and three men; age range 42–65 years, mean 53.6 years; Fitzpatrick skin phototypes II–III) with solar lentigines underwent treatment with a 532 nm green laser (QuadroStarPRO GREEN, Asclepion) using a standardized, single-session protocol. Outcomes were assessed at the final available follow-up (day 21) by 2 independent dermatologists using a retrospective categorical response classification (complete response/partial response/no response) based on paired baseline and day 21 image documentation only; patient satisfaction was recorded at day 21 on a 0–10 visual analog scale (VAS). A narrative review with a structured PubMed/Medline literature search was conducted to identify clinical studies evaluating 532 nm KTP/green laser devices for lentigines, freckles, and ephelides. Results: All five target lesions were classified as complete response at day 21 (5/5 complete response), with a mean VAS satisfaction score of 8.6/10 (range, 7–10) and no discordance between dermatologists. Mild transient erythema was observed immediately after treatment and improved within the first day; no persistent adverse events, dyschromia, or scarring were observed during the available 21-day follow-up. Conclusions: In this small case series, a single-session millisecond 532 nm green laser protocol was associated with complete-response classification at day 21 in five target lesions. Published clinical studies indicate that outcomes with 532 nm devices vary with device type, pulse structure, and treatment settings; larger comparative studies with objective pigment measures and longer follow-ups are needed. Full article

This study evaluated the safety and effectiveness of HYDRAGEL A2, an injectable medical device containing hyaluronic acid (HA), polynucleotides (PN), and niacinamide, for improving facial skin quality. These ingredients are increasingly recognized for their synergistic effects in aesthetic medicine, with HA and PN providing hydration and skin support, and niacinamide offering anti-inflammatory and antioxidant properties. A prospective, open-label clinical investigation was conducted on 42 female subjects (mean age 45 ± 1 years, Fitzpatrick skin phototypes II-V) to assess skin elasticity, hydration, and mild skin depression correction following cheek area injections. Efficacy was measured using the Global Aesthetic Improvement Scale (GAIS), Antera 3D^® (texture), Cutometer^® (elasticity/firmness), Corneometer^® (hydration), and Dermascan^® (density/thickness) devices at baseline (D0), week 2 (W2/D14), and week 6 (W6/D42). GAIS values showed significant overall facial improvement (p < 0.001) by both investigators and subjects, where 100% of subjects rated their appearance as improved immediately post-injection (D0), with sustained improvements at D42. Objective measurements revealed significant improvements in skin texture (reduced roughness), elasticity, firmness, hydration (p < 0.001), density, and thickness, demonstrating the combined benefits of the HA, PN, and niacinamide blend. Injection site reactions, primarily mild and transient, were reported immediately post-injection. Investigators and subjects reported high satisfaction with the product’s ease of use and aesthetic outcomes. Globally, HYDRAGEL A2, leveraging the established benefits of HA, PN, and niacinamide, was well-tolerated and effectively enhanced facial skin quality, demonstrating significant and sustained improvements in monitored skin parameters. The study concludes that this combination of ingredients, formulated in HYDRAGEL A2, provides a well-tolerated approach associated with improvements in skin quality. Full article

Background: Directional hemispherical reflectance (DHR) is a precise method for evaluating skin reflectance and is widely used in dermatological, photobiological, and cosmetic or pharmaceutical research. Reflectance measurements may support emissivity-related interpretation, particularly in the infrared range, being influenced by chromophore content, epidermal structure, and physiological factors such as hydration, pigmentation, and surface heterogeneity. However, most in vivo studies have focused on limited spectral ranges or selected anatomical sites. This study aimed to assess skin directional hemispherical reflectance across a broad spectral range and to provide an integrated dataset supporting emissivity-related interpretation in the infrared region. Methods: The study included 20 women aged 22–50 years (27 ± 9 years) with Fitzpatrick skin phototypes II–III. Reflectance measurements were performed at 14 anatomical sites using an ET 100 emissometer (1.9–21 µm) and an SOC 410 Solar DHR reflectometer (335–2500 nm). Infrared measurements were conducted at incidence angles of 20° and 60° to assess angular effects. Data were statistically analyzed. Results: The lowest reflectance values were observed within 335–380 nm, 1700–2500 nm, and 1.5–21 µm, whereas the highest reflectance was recorded in the 590–720 nm and 700–1100 nm bands. Reflectance symmetry between body sides was observed. In the infrared range, reflectance decreased with increasing wavelength, while mid- and far-infrared values were more uniform across locations. The highest reflectance values were noted for the thigh, calf (crural region), forearm, and palmar surface of the hand, whereas the lowest values were observed in the neck, abdominal region, and dorsal surface of the hand. Measurements at 60° incidence yielded higher reflectance values than those at 20°, while preserving spatial patterns. Conclusions: Directional hemispherical reflectance provides a robust approach for assessing skin reflectance across a broad spectral range. Reflectance depends on wavelength, anatomical location, and physiological factors, including epidermal thickness, pigmentation, and sebum presence. The integrated analysis of spectral, anatomical, and angular variability may support improved interpretation of skin optical properties and contribute to reference data for biomedical and infrared imaging applications. Full article

Background: Dermatology and aesthetic medicine make extensive use of microneedling, a minimally invasive and safe treatment. Across the research, it has been shown that microneedling combined with chemical peels is also more effective than chemical peels alone. However, data on procedures in dark-skinned individuals is rather scarce. Aim/Objective: This study aimed to determine the efficacy of using a 4% retinol solution product containing novel TGF-β activators and antioxidants combined with a microneedling technique in the treatment of hyperpigmentation, atrophic acne scars, and enlarged pores in patients with skin of color, generally corresponding to Fitzpatrick skin phototypes IV–VI. Methods: Each of the 10 patients underwent three peel treatment series, with a 30-day interval between each session. Moreover, skin hydration, elasticity, and pigmentation were examined using the Multi Skin Test MC 1000 Courage + Khazaka, and the Observ 520x device. Results: All patients reported an overall improvement and an enhancement in skin tone after the procedure. The majority of them stated subjective improvement in the reduction of facial skin issues: redness, hyperpigmentation, uneven structure, wrinkles, dehydration, dryness, and sebaceous gland activity. The least improvement was noted in scar reduction or liquidation. An objective evaluation revealed a statistically significant improvement in hyperpigmentation and elasticity in the study group. An improvement, however, not statistically significant, in hydration parameters was demonstrated during the study. Conclusions: This study suggests that a combined peel therapy of 4% retinol serum product containing novel TGF-β activators and antioxidants, together with a microneedling technique, may improve facial hyperpigmentation of the skin, as well as regulate sebaceous gland activity, their size, and reduce sebum production. The recommended method is relatively simple to use, low-cost, has minimal adverse effects, and is well tolerated by patients with skin of color. Full article

Background: Patient-perceived seasonality of psoriasis is frequently reported, yet the independent contribution of objectively quantified, individualized ultraviolet (UV) exposure remains insufficiently characterized. We evaluated seasonal variation in plaque psoriasis and its association with geocoded, phototype-adjusted ambient antipsoriatic radiant exposures (ARE) using mixed-effects modeling. Methods: This cross-sectional study included 119 adults with plaque psoriasis (476 seasonal observations). Participants rated seasonal disease courses using a 7-point scale. Ambient ARE was geocoded to residential postal codes and quantified as a behaviorally weighted dose normalized to individual minimal erythema dose (MED). Mixed-effects logistic regression models, adjusted for relevant confounders, estimated associations with seasonal improvement and worsening. Results: Seasonality was reported by 89.9% of participants (p < 0.001). Summer was the most favorable season, whereas winter was the most detrimental. The highest ARE quartile was independently associated with increased odds of improvement (OR 4.65, 95% CI 2.04–10.58, p < 0.001) and reduced odds of worsening (OR 0.16, 95% CI 0.08–0.33, p < 0.001). Crucially, continuous quadratic modeling revealed a significant inverted U-shaped relationship between UV exposure and improvement, with an estimated turning point of 3.85 (95% CI 1.88–5.82, p < 0.001) for the declared daily ARE (UV_decl) normalized by MED. Beyond this threshold, the probability of improvement attenuated. The protective effect against seasonal worsening remained linear. Conclusions: Psoriasis seasonality demonstrates a robust exposure–response association relationship with ambient UV. The estimated turning point (UV_decl/MED = 3.85) within our modeled exposure metric is exploratory and hypothesis-generating. It suggests an association where moderate UV exposure correlates with patient-perceived benefits, but these diminish at very high levels. This threshold requires external prospective validation before being considered a clinically actionable recommendation. Full article

Cutaneous squamous cell carcinoma (cSCC) is the second most prevalent skin cancer diagnosed worldwide after basal cell carcinoma. CSCC represents a growing global public health challenge due to its higher potential of local invasion, recurrence, and metastasis. Incidence rates of cSCC are projected to increase due to rising exposures to risks factors. Ultraviolet light exposure is the primary cause, and lighter skin pigmentation, immunosuppressive conditions and skin phototype are the primary risk factors. CSCC typically presents as a red, scaly, flat lesion (in situ tumors) or a red, firm, raised lesion with scale or erosion (invasive tumors). Surgical excision remains the standard-of-care for localized cSCC and is often curative. Although, most patients achieve favorable outcomes, a subset of cSCC exhibits a highly aggressive and metastatic phenotype (postoperative recurrence rates are approximately 5%). Addressing the clinical challenge posed by these high-risk cases requires a more comprehensive understanding of the underlying molecular drivers. This review examines the interaction between transglutaminase 2 (TG2) and the G-protein-coupled receptor 56 (GPR56) as a pivotal driver of the aggressive cSCC phenotype. This molecular axis is particularly significant for its role in the maintenance of epidermal cancer stem (ECS) cells, which contribute to tumor progression and therapy resistance. While the definitive link between the TG2-GPR56 complex and systemic metastasis in cSCC is currently being elucidated, significant evidence from analogous malignancies and in vitro keratinocyte models provides a clear mechanistic roadmap for its involvement in tumor invasion. Full article

Background: Human cutaneous reactivity exhibits marked inter-individual variability, yet the contribution of constitutional pigmentation traits to short-term skin responses remains incompletely characterized. Fitzpatrick skin phototype reflects stable differences in pigmentation-related traits and may therefore act as a phenotypic modifier of early cutaneous reactivity following topical exposure. Methods: In this controlled human study, 239 healthy volunteers were stratified by Fitzpatrick skin phototype into three groups: I–II (n = 138), III (n = 72), and IV–V (n = 29). A standardized emulgel-based topical provocation model was applied under occlusion to the volar forearm, and cutaneous responses were assessed at 20 min (Test A), 24 h (Test B), and 96 h (Test C) using standardized visual scoring. Group comparisons, multivariable linear regression models adjusted for age, sex, country of origin, and experimental lot, and stratified analyses by country of origin, were performed. Results: Early and short-term cutaneous responses differed significantly across phototype groups. Participants with phototypes I–II exhibited higher response scores at both 20 min and 24 h compared with phototype III (p < 0.001). In adjusted models, phototype III remained independently associated with significantly lower reactivity relative to phototypes I–II at 20 min (β = −1.61, p < 0.001) and 24 h (β = −0.98, p < 0.001). Responses among phototypes IV–V were minimal to absent; however, this subgroup was underrepresented, and findings for IV–V are descriptive. Age was a significant positive predictor of response intensity, whereas sex showed no independent association. No persistent reactions were observed at 96 h in any phototype group. Stratified analyses confirmed that the reduced reactivity associated with phototype III was independent of country of origin. Conclusions: Fitzpatrick skin phototype is independently associated with early and short-term cutaneous reactivity following standardized topical provocation in humans. Lighter phototypes (I–II) demonstrate increased susceptibility to transient inflammatory responses, whereas phototype III shows markedly reduced reactivity. These findings support the role of skin phototype as a constitutional modifier of short-term cutaneous responses and highlight the importance of considering pigmentation-related phenotypes in the design and interpretation of dermatological testing, cosmetic tolerability studies, and safety assessments of topical formulations. Full article

Objective: This study aimed to design and clinically evaluate a bespoke cosmetic formulation tailored to individual skin characteristics and user preferences, focusing on hydration and barrier recovery in mature, therapy-affected skin. In addition, this study aimed to explore the feasibility and short-term outcomes of a structured, biometry-driven personalization approach applied within a single-subject case study design. Materials and Methods: A personalized dermato-cosmetic formulation incorporating melatonin, astaxanthin, low-molecular-weight hyaluronic acid, allantoin, yarrow oil (Achillea millefolium), lecithin, cholesterol, and arginine was developed based on objective biophysical assessment of the skin. A clinical case evaluation was conducted in a male subject over 55 years of age (Fitzpatrick phototype III) presenting persistent xerosis and dehydration following completed oncologic therapy. Quantitative skin biometry was performed at baseline and after 28 days of daily application, assessing hydration at six anatomical sites, sebum secretion, pigmentation and erythema indices, elasticity, and stratum corneum turnover and scaling. Results: After 28 days, sebum secretion increased by more than 100%, indicating partial restoration of the lipid barrier. Hyperpigmented areas decreased from 7.2% to 2.3%, while skin elasticity improved from 25% to 44%. A reduction of 8% in the erythema index suggested decreased vascular reactivity. Hydration levels improved consistently across all evaluated sites, and epidermal renewal was enhanced, as evidenced by reduced scaling and smoother skin surface. The melanin index remained stable throughout the study period. Conclusions: This pilot evaluation shows that bespoke cosmetic formulations, customized to individual skin biometry and preferences, can yield measurable improvements in hydration, barrier repair, elasticity, pigmentation uniformity, and epidermal renewal within 28 days, even in skin compromised by previous oncologic therapy. Given the single-subject nature of this pilot evaluation, these findings cannot be generalized to broader populations but rather highlight the importance of personalization and objective skin assessment in guiding individualized dermato-cosmetic formulation strategies. Personalized dermato-cosmetology using objective biophysical assessment may be a promising future strategy for effective, consumer-centered skincare. Full article

We determined the in vivo absorption coefficient (μ_a) for 82 test subjects, all classified as Fitzpatrick skin phototypes II, III, IV, and V. Measurements were conducted using the integrating-sphere technique on the dorsal and palmar surfaces of the hand and the forearm. The reflectance data obtained were processed using the Inverse Adding Doubling algorithm to calculate the absorption coefficient. The mean values for this parameter ranged from 0.0132 mm⁻¹ to 0.1021 mm⁻¹ at a central wavelength of 624 nm. It was found that these parameters may be grouped into a distinct cohort, paving the way for studies and the design of light-based diagnostics and treatments better suited to the population in Mexico and Latin America. Full article

Background/Objectives: Hypopigmented mycosis fungoides (hMF) is a rare variant of mycosis fungoides (MF) often seen in younger patients and individuals with darker skin phototypes. The lesions develop as hypopigmented patches or plaques, and they are usually asymptomatic and respond well to topical treatment or phototherapy. Methods: We provide a systematic review on hMF with onset at or beyond 30 years of age, based on SCOPUS, PubMed, and Embase databases. A total of 13 original articles, totaling 34 patients, were included in this review. Evidence was limited to case reports and small series; PROSPERO registration is CRD420251181894. Results: The majority of cases did not progress beyond stage IB and commonly used treatment methods, including topical corticosteroids and phototherapy. In three patients, a progression of the disease occurred, and in two of them it was fetal. Among patients receiving phototherapy, PUVA therapy achieved complete remission more often than UVB (13 out of 17 cases vs. 8 out of 16 cases). Although recurrences occurred with both treatments, they were less frequent, and relapses took longer to develop in the PUVA group. Conclusions: In this cohort, PUVA appeared to be associated with higher complete response rates and longer remission duration than UVB. However, this advantage of PUVA is derived from low-level evidence and should be confirmed in prospective comparative studies. Full article

Breslow thickness (BT) is the most powerful prognostic indicator in cutaneous melanoma, yet histopathological measurement exhibits some limitations such as interobserver variability and diagnostic delays. Preoperative clinical assessment demonstrates 30% misclassification rates. This narrative review synthesizes evidence on deep learning models for non-invasive BT estimation from dermoscopic images. Convolutional neural networks (ResNet, EfficientNet, Vision Transformers) with transfer learning from ImageNet achieve up to 75–79% accuracy and AUC 0.76–0.85 on single-center datasets. Preprocessing techniques (hair removal, color normalization, data augmentation) and interpretability methods (Grad-CAM, LIME) enhance clinical applicability. However, external validation reveals performance degradation. The clinically critical thickness range (0.4–1.0 mm) demonstrates poor discrimination. Significant dataset bias exists: most training data represents lighter skin phototypes, resulting in an underrepresentation of darker skin types. AI models function as complementary decision-support tools rather than replacements for histopathology. Prospective clinical trials validating clinical utility are lacking, and regulatory approval pathways are undefined. Research priorities include diverse public datasets with balanced skin tone representation, the adoption of threshold-weighted loss functions to prioritize accuracy at the 0.8 mm surgical cut-off, multi-institutional external validation, prospective randomized trials, federated learning frameworks, and regulatory engagement. Only rigorous, equitable research can translate AI from proof-of-concept to clinically reliable tools benefiting all melanoma patients. Full article

Skin scars represent a complex therapeutic challenge, with significant functional, aesthetic, and psychological implications. Despite advances in laser therapy, monotherapy has significant limitations, particularly for patients with complex scars with atrophic, hypertrophic, vascular, and pigmentary components. The combined use of multiple laser sources, in sequential or simultaneous mode, allows for the selective targeting of specific tissue components and improves clinical efficacy while maintaining a good safety profile. This narrative review critically analyses the available evidence on combination therapies for atrophic, hypertrophic, keloid, and post-surgical and burn scars. Protocols combining ablative lasers (CO₂, Er:YAG), non-ablative lasers (1540–1550 nm), vascular lasers (PDL, Nd:YAG) and intense pulsed light (IPL) are reported. Possible integrations with adjuvant techniques, such as radiofrequency, platelet-rich plasma (PRP), and laser-assisted drug delivery, are also mentioned as areas for future development. The available data suggest a promising role for multimodal strategies, but the literature remains limited by small cohorts, heterogeneous protocols, and short follow-up periods. Although adverse events are generally mild and transient, typically involving erythema, oedema, or temporary dyschromia, an awareness of safety considerations remains essential, particularly in higher phototypes and when using ablative modalities. Further prospective and multicentre studies are needed to define standardised protocols and consolidate the role of combination therapies in the management of scars. Full article

Background and Objectives: To our knowledge, this is the first case–control study conducted in the Baltic countries that identified CM risk factors focusing on the investigated subjects’ phenotypic traits, severe sunburns, sunscreen and tanning bed use. Materials and Methods: This study analyses 180 subjects with CM (case group) and 182 randomly selected controls. All participants completed surveys about sun exposure habits and skin phototype (I–IV) according to the Fitzpatrick scale. Skin, eye, and hair colour, number of freckles, and melanocytic nevi greater than 2 mm in diameter (MN > 2 mm) on sites with maximal, intermittent, and minimal sun exposure were examined. Results: We determined five risk factors that significantly increased the odds ratio of CM (OR; 95% confidence interval): tanning bed use compared to non-use (6.46; 1.89–22.96), lack of sunscreen use compared to regular use (7.41; 2.88–19.09), and fair skin compared to medium and olive skin (2.06; 1.03–4.09). The probability of CM also increased with each instance of severe sunburn (2.57; 1.96–3.38) and with each additional MN > 2 mm in sun-exposed areas (1.05; 1.03–1.07). Conclusions: The results of this case–control study offer novel insights into modifiable risk factors for CM, highlighting potential targets for primary prevention strategies in the Baltic countries’ population, with dominant fair phenotypic traits of skin, eye, and hair colour. Full article